Biochips Market Size, Share, Trends, Growth and Forecast 2028
Biochips Market By Product (DNA Chip, Protein Chip, and Lab-on-a-chip), By Application (Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, and Agriculture), End User (Biotechnology & Pharmaceutical Companies, Hospitals & Diagnostics Centers, and Academic & Research Institutes) and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2022 - 2028
| Market Size in 2021 | Market Forecast in 2028 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 12,005 Million | USD 25,568 Million | 11.3% | 2021 |
Table Of Content
- Chapter 1. Preface
- 1.1. Report Description and Scope
- 1.2. Research Scope
- 1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology
- Chapter 2. Executive Summary
- 2.1. Biochips, 2016-2025 (USD Million)
- 2.2. Biochips: Snapshot
- Chapter 3. Biochips - Industry Analysis
- 3.1. Biochips: Market Dynamics
- 3.2. Market Drivers
- 3.2.1. Growing prevalence of cancer
- 3.2.2. Increasing incidence of viral infections and immunological disorders
- 3.3. Restraints
- 3.3.1. High cost of biochips
- 3.3.2. Low awareness in developing regions
- 3.4. Opportunity
- 3.4.1. Technological advancements
- 3.4.2. High investment in research and development
- 3.5. Porter's Five Forces Analysis
- 3.6. Market Attractiveness Analysis
- 3.6.1. Market attractiveness analysis By Product
- 3.6.2. Market attractiveness
- analysis By Application
- 3.6.3. Market attractiveness analysis By End User
- 3.6.4. Market attractiveness analysis by Region
- Chapter 4. Biochips- Competitive Landscape
- 4.1. Company market share analysis
- 4.1.1. Global Biochips: company market share, 2018
- 4.2. Strategic development
- 4.2.1. Acquisitions & mergers
- 4.2.2. New product launches
- 4.2.3. Agreements, partnerships, collaborations and joint ventures
- 4.2.4. Research and development and Regional expansion
- 4.3. Price trend analysis
- 4.1. Company market share analysis
- Chapter 5. Global Biochips -Product Analysis
- 5.1. Global Biochips overview: By Product type
- 5.1.1. Global Biochips share, By Product,2018 and 2025
- 5.2. Lab-on-a-chip
- 5.2.1. Global Biochips by Lab-on-a-chip, 2016-2025 (USD Million)
- 5.3. Protein Chip
- 5.3.1. Global Biochips by Protein Chip, 2016-2025 (USD Million)
- 5.4. DNA Chip
- 5.4.1. Global Biochips by DNA Chip, 2016-2025 (USD Million)
- 5.5. Resilience Training
- 5.5.1. Global Biochips by Resilience Training, 2016-2025 (USD Million)
- 5.6. Others
- 5.6.1. Global Biochips by others, 2016-2025 (USD Million)
- 5.1. Global Biochips overview: By Product type
- Chapter 6. Global Biochips -Application Analysis
- 6.1. Global Biochips overview: By Application
- 6.1.1. Global Biochips share, By Application, 2018 and 2025
- 6.2. Disease Diagnostics
- 6.2.1. Global Biochips By Disease Diagnostics, 2016-2025 (USD Million)
- 6.3. Drug Development & Discovery
- 6.3.1. Global Biochips By Drug Development & Discovery, 2016-2025 (USD Million)
- 6.4. Proteomics
- 6.4.1. Global Biochips By Proteomics, 2016-2025 (USD Million)
- 6.5. Agriculture
- 6.5.1. Global Biochips By Agriculture, 2016-2025 (USD Million)
- 6.6. Genomics
- 6.6.1. Global Biochips By Genomics, 2016-2025 (USD Million)
- 6.7. Others
- 6.7.1. Global Biochips by Other Applications, 2016-2025 (USD Million)
- 6.1. Global Biochips overview: By Application
- Chapter 7. Global Biochips -End User Analysis
- 7.1. Global Biochips overview: By End User
- 7.1.1. Global Biochips share, By End User, 2018 and 2025
- 7.2. Hospitals
- 7.2.1. Global Biochips by Hospitals, 2016-2025 (USD Million)
- 7.3. Diagnostics Centers
- 7.3.1. Global Biochips by Diagnostics Centers, 2016-2025 (USD Million)
- 7.4. Pharmaceutical & Biotechnology Companies
- 7.4.1. Global Biochips by Pharmaceutical & Biotechnology Companies, 2016-2025 (USD Million)
- 7.5. Research & Academic Institutes
- 7.5.1. Global Biochips by Research & Academic Institutes, 2016-2025 (USD Million)
- 7.6. Others
- 7.6.1. Global Biochips by Others, 2016-2025 (USD Million)
- 7.1. Global Biochips overview: By End User
- Chapter 8. Global Biochips - Regional Analysis
- 8.1. Global Biochips overview: by Region
- 8.1.1. Global Biochips share, by Region, 2018 and 2025
- 8.2. North America
- 8.2.1. North America Biochips, 2016-2025 (USD Million)
- 8.2.2. North America Biochips revenue, By Product,2016-2025 (USD Million)
- 8.2.3. North America Biochips revenue, By Application, 2016-2025 (USD Million)
- 8.2.4. North America Biochips revenue, By End User, 2016-2025 (USD Million)
- 8.2.5. The U.S.
- 8.2.5.1. The U.S. Biochips revenue, By Product,2016-2025 (USD Million)
- 8.2.5.2. The U.S. Biochips revenue, By Application, 2016-2025 (USD Million)
- 8.2.5.3. The U.S. Biochips revenue, By End User, 2016-2025 (USD Million)
- 8.2.6. Rest of North America
- 8.2.6.1. Rest of North America Biochips revenue, By Product,2016-2025 (USD Million)
- 8.2.6.2. Rest of North America Biochips revenue, By Application, 2016-2025 (USD Million)
- 8.2.6.3. Rest of North America Biochips revenue, By End User, 2016-2025 (USD Million)
- 8.3. Europe
- 8.3.1. Europe Biochips, 2016-2025 (USD Million)
- 8.3.2. Europe Biochips revenue, By Product,2016-2025 (USD Million)
- 8.3.3. Europe Biochips revenue, By Application, 2016-2025 (USD Million)
- 8.3.4. Europe Biochips revenue, By End User, 2016-2025 (USD Million)
- 8.3.5. UK
- 8.3.5.1. U.K. Biochips revenue, By Product,2016-2025 (USD Million)
- 8.3.5.2. U.K. Biochips revenue, By Application, 2016-2025 (USD Million)
- 8.3.5.3. U.K. Biochips revenue, By End User, 2016-2025 (USD Million)
- 8.3.6. France
- 8.3.6.1. France Biochips revenue, By Product,2016-2025 (USD Million)
- 8.3.6.2. France Biochips revenue, By Application, 2016-2025 (USD Million)
- 8.3.6.3. France Biochips revenue, By End User, 2016-2025 (USD Million)
- 8.3.7. Germany
- 8.3.7.1. Germany Biochips revenue, By Product,2016-2025 (USD Million)
- 8.3.7.2. Germany Biochips revenue, By Application, 2016-2025 (USD Million)
- 8.3.7.3. Germany Biochips revenue, By End User, 2016-2025 (USD Million)
- 8.3.8. Rest of Europe
- 8.3.8.1. Rest of Europe Biochips revenue, By Product,2016-2025 (USD Million)
- 8.3.8.2. Rest of Europe Biochips revenue, By Application, 2016-2025 (USD Million)
- 8.3.8.3. Rest of Europe Biochips revenue, By End User, 2016-2025 (USD Million)
- 8.4. Asia Pacific
- 8.4.1. Asia Pacific Biochips, 2016-2025 (USD Million)
- 8.4.2. Asia Pacific Biochips revenue, By Product,2016-2025 (USD Million)
- 8.4.3. Asia Pacific Biochips revenue, By Application, 2016-2025 (USD Million)
- 8.4.4. Asia Pacific Biochips revenue, By End User, 2016-2025 (USD Million)
- 8.4.5. China
- 8.4.5.1. China Biochips revenue, By Product,2016-2025 (USD Million)
- 8.4.5.2. China Biochips revenue, By Application, 2016-2025 (USD Million)
- 8.4.5.3. China Biochips revenue, By End User, 2016-2025 (USD Million)
- 8.4.6. Japan
- 8.4.6.1. Japan Biochips revenue, By Product,2016-2025 (USD Million)
- 8.4.6.2. Japan Biochips revenue, By Application, 2016-2025 (USD Million)
- 8.4.6.3. Japan Biochips revenue, By End User, 2016-2025 (USD Million)
- 8.4.7. India
- 8.4.7.1. India Biochips revenue, By Product,2016-2025 (USD Million)
- 8.4.7.2. India Biochips revenue, By Application, 2016-2025 (USD Million)
- 8.4.7.3. India Biochips revenue, By End User, 2016-2025 (USD Million)
- 8.4.8. Rest of Asia Pacific
- 8.4.8.1. Rest of Asia Pacific Biochips revenue, By Product,2016-2025 (USD Million)
- 8.4.8.2. Rest of Asia Pacific Biochips revenue, By Application, 2016-2025 (USD Million)
- 8.4.8.3. Rest of Asia Pacific Biochips revenue, By End User, 2016-2025 (USD Million)
- 8.5. Latin America
- 8.5.1. Latin America Biochips, 2016-2025 (USD Million)
- 8.5.2. Latin America Biochips revenue, By Product,2016-2025 (USD Million)
- 8.5.3. Latin America Biochips revenue, By Application, 2016-2025 (USD Million)
- 8.5.4. Latin America Biochips revenue, By End User, 2016-2025 (USD Million)
- 8.5.5. Brazil
- 8.5.5.1. Brazil Biochips revenue, By Product,2016-2025 (USD Million)
- 8.5.5.2. Brazil Biochips revenue, By Application, 2016-2025 (USD Million)
- 8.5.5.3. Brazil Biochips revenue, By End User, 2016-2025 (USD Million)
- 8.5.6. Rest of Latin America
- 8.5.6.1. Rest of Latin America Biochips revenue, By Product,2016-2025 (USD Million)
- 8.5.6.2. Rest of Latin America Biochips revenue, By Application, 2016-2025 (USD Million)
- 8.5.6.3. Rest of Latin America Biochips revenue, By End User, 2016-2025 (USD Million)
- 8.6. The Middle East and Africa
- 8.6.1. The Middle East and Africa Biochips, 2016-2025 (USD Million)
- 8.6.2. The Middle East and Africa Biochips revenue, By Product,2016-2025 (USD Million)
- 8.6.3. The Middle East and Africa Biochips revenue, By Application, 2016-2025 (USD Million)
- 8.6.4. The Middle East and Africa Biochips revenue, By End User, 2016-2025 (USD Million)
- 8.1. Global Biochips overview: by Region
- Chapter 9. Company Profiles
- 9.1. Bio-Rad Laboratories, Inc.
- 9.1.1. Overview
- 9.1.2. Financials
- 9.1.3. Product Portfolio
- 9.1.4. Business Strategy
- 9.1.5. Recent Developments
- 9.2. bioMérieux SA
- 9.2.1. Overview
- 9.2.2. Financials
- 9.2.3. Product Portfolio
- 9.2.4. Business Strategy
- 9.2.5. Recent Developments
- 9.3. Illumina, Inc.
- 9.3.1. Overview
- 9.3.2. Financials
- 9.3.3. Product Portfolio
- 9.3.4. Business Strategy
- 9.3.5. Recent Developments
- 9.4. F. Hoffmann-La Roche AG
- 9.4.1. Overview
- 9.4.2. Financials
- 9.4.3. Product Portfolio
- 9.4.4. Business Strategy
- 9.4.5. Recent Developments
- 9.5. Thermo Fisher Scientific Inc.
- 9.5.1. Overview
- 9.5.2. Financials
- 9.5.3. Product Portfolio
- 9.5.4. Business Strategy
- 9.5.5. Recent Development
- 9.6. Fluidigm Corporation
- 9.6.1. Overview
- 9.6.2. Financials
- 9.6.3. Product Portfolio
- 9.6.4. Business Strategy
- 9.6.5. Recent Development
- 9.7. HORIBA, Ltd.
- 9.7.1. Overview
- 9.7.2. Financials
- 9.7.3. Product Portfolio
- 9.7.4. Business Strategy
- 9.7.5. Recent Development
- 9.8. PerkinElmer, Inc.
- 9.8.1. Overview
- 9.8.2. Financials
- 9.8.3. Product Portfolio
- 9.8.4. Business Strategy
- 9.8.5. Recent Development
- 9.9. PerkinElmer, Inc.
- 9.9.1. Overview
- 9.9.2. Financials
- 9.9.3. Product Portfolio
- 9.9.4. Business Strategy
- 9.9.5. Recent Development
- 9.10. QIAGEN N.V.
- 9.10.1. Overview
- 9.10.2. Financials
- 9.10.3. Product Portfolio
- 9.10.4. Business Strategy
- 9.10.5. Recent Development
- 9.1. Bio-Rad Laboratories, Inc.
Table Of Figures
List of Figures
1. Market research process
2. Market research methodology
3. Global Biochips, 2016–2025 (USD Million)
4. Porter’s Five Forces Analysis
5. Global Biochips attractiveness, By Product type
6. Global Biochips attractiveness, By Application
7. Global Biochips attractiveness, By End User
8. Global Biochips market share, By Product, 2018 and 2025
9. Global Biochips by Lab-on-a-chip, 2016–2025 (USD Million)
10. Global Biochips by Protein Chip,2016–2025 (USD Million)
11. Global Biochips by DNA Chip,2016–2025 (USD Million)
12. Global Biochips by Others,2016–2025 (USD Million)
13. Global Biochips share, By Application, 2018 and 2025
14. Global Biochips By Disease Diagnostics, 2016–2025 (USD Million)
15. Global Biochips By Drug Development & Discovery, 2016–2025 (USD Million)
16. Global Biochips By Proteomics, 2016–2025 (USD Million)
17. Global Biochips By Agriculture, 2016–2025 (USD Million)
18. Global Biochips By Genomics, 2016–2025 (USD Million)
19. Global Biochips By Others, 2016–2025 (USD Million)
20. Global Biochips share, By End User, 2018 and 2025
21. Global Biochips by Hospitals, 2016–2025 (USD Million)
22. Global Biochips by Diagnostics Centers, 2016–2025 (USD Million)
23. Global Biochips by Pharmaceutical & Biotechnology Companies, 2016–2025 (USD Million)
24. Global Biochips by Pharmaceutical & Biotechnology Companies, 2016–2025 (USD Million)
25. Global Biochips by Others, 2016–2025 (USD Million)
26. Global Biochips share, by Region, 2018and 2025
27. North America Biochips, 2016–2025 (USD Million)
28. Europe Biochips, 2016–2025 (USD Million)
29. Asia Pacific Biochips, 2016–2025 (USD Million)
30. Latin America Biochips, 2016–2025 (USD Million)
31. The Middle East and Africa Biochips, 2016–2025 (USD Million)
Table Of Tables
List of Tables
1. Global Biochips: snapshot
2. Drivers of the Biochips: impact analysis
3. Restraints of the Biochips: impact analysis
4. North America Biochips revenue, By Product,2016–2025 (USD Million)
5. North America Biochips revenue, By Application, 2016–2025 (USD Million)
6. North America Biochips revenue, By End User, 2016–2025 (USD Million)
7. The U.S. Biochips revenue, By Product,2016–2025 (USD Million)
8. The U.S. Biochips revenue, By Application, 2016–2025 (USD Million)
9. The U.S. Biochips revenue, By End User, 2016–2025 (USD Million)
10. Rest of North America Biochips revenue, By Product,2016–2025 (USD Million)
11. Rest of North America Biochips revenue, By Application, 2016–2025 (USD Million)
12. Rest of North America Biochips revenue, By End User, 2016–2025 (USD Million)
13. Europe Biochips revenue, By Product,2016–2025 (USD Million)
14. Europe Biochips revenue, By Application, 2016–2025 (USD Million)
15. Europe Biochips revenue, By End User, 2016–2025 (USD Million)
16. U.K. Biochips revenue, By Product,2016–2025 (USD Million)
17. U.K. Biochips revenue, By Application, 2016–2025 (USD Million)
18. U.K. Biochips revenue, By End User, 2016–2025 (USD Million)
19. France Biochips revenue, By Product,2016–2025 (USD Million)
20. France Biochips revenue, By Application, 2016–2025 (USD Million)
21. France Biochips revenue, By End User, 2016–2025 (USD Million)
22. Germany Biochips revenue, By Product,2016–2025 (USD Million)
23. Germany Biochips revenue, By Application, 2016–2025 (USD Million)
24. Germany Biochips revenue, By End User, 2016–2025 (USD Million)
25. Rest of Europe Biochips revenue, By Product,2016–2025 (USD Million)
26. Rest of Europe Biochips revenue, By Application, 2016–2025 (USD Million)
27. Rest of Europe Biochips revenue, By End User, 2016–2025 (USD Million)
28. Asia Pacific Biochips revenue, By Product,2016–2025 (USD Million)
29. Asia Pacific Biochips revenue, By Application, 2016–2025 (USD Million)
30. Asia Pacific Biochips revenue, By End User, 2016–2025 (USD Million)
31. China Biochips revenue, By Product,2016–2025 (USD Million)
32. China Biochips revenue, By Application, 2016–2025 (USD Million)
33. China Biochips revenue, By End User, 2016–2025 (USD Million)
34. Japan Biochips revenue, By Product,2016–2025 (USD Million)
35. Japan Biochips revenue, By Application, 2016–2025 (USD Million)
36. Japan Biochips revenue, By End User, 2016–2025 (USD Million)
37. India Biochips revenue, By Product,2016–2025 (USD Million)
38. India Biochips revenue, By Application, 2016–2025 (USD Million)
39. India Biochips revenue, By End User, 2016–2025 (USD Million)
40. Rest of Asia Pacific Biochips revenue, By Product,2016–2025 (USD Million)
41. Rest of Asia Pacific Biochips revenue, By Application, 2016–2025 (USD Million)
42. Rest of Asia Pacific Biochips revenue, By End User, 2016–2025 (USD Million)
43. Latin America Biochips revenue, By Product,2016–2025 (USD Million)
44. Latin America Biochips revenue, By Application, 2016–2025 (USD Million)
45. Latin America Biochips revenue, By End User, 2016–2025 (USD Million)
46. Brazil Biochips revenue, By Product,2016–2025 (USD Million)
47. Brazil Biochips revenue, By Application, 2016–2025 (USD Million)
48. Brazil Biochips revenue, By End User, 2016–2025 (USD Million)
49. Rest of Latin America Biochips revenue, By Product,2016–2025 (USD Million)
50. Rest of Latin America Biochips revenue, By Application, 2016–2025 (USD Million)
51. Rest of Latin America Biochips revenue, By End User, 2016–2025 (USD Million)
52. The Middle East and Africa Biochips revenue, By Product,2016–2025 (USD Million)
53. The Middle East and Africa Biochips revenue, By Application, 2016–2025 (USD Million)
54. The Middle East and Africa Biochips revenue, By End User, 2016–2025 (USD Million)
Methodology
FrequentlyAsked Questions
Biochip technologies are widely deployed across different areas, including microbiology, DNA analysis, clinical pathology, pharmacology, proctology, and biochemistry, among others. The ongoing research activities will fuel the usage of biochip technologies, particularly in the healthcare industry, which in turn will further expand the usage of biochips in the mainstream market in the forthcoming years.
The global market was valued at $12,005 million in 2021 and is projected to reach $25,568 million in 2028. The market is likely to grow with a high CAGR of 11.3% during the forecast period.
Some of the significant players in the global biochip market include Thermo Fisher Scientific Inc., Randox Laboratories Ltd., PerkinElmer, Inc., Illumina, Inc., Fluidigm Corporation, F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories, Inc., and bioMerieux S.A.
Asia Pacific accounts for the largest share in the global biochip market due to the fast proliferating pharmaceutical and healthcare sector in the region. Also, the increasing investment in biochip technologies is further likely to complement the growth of the regional market.
Choose License Type
List of Contents
Market Size And Industry AnalysisBiochip OverviewMarket Concentration CharacteristicsCOVID-19 Impact:Biochip Growth DriversBiochip RestraintsBiochip ChallengesBiochip OpportunitiesBiochip SegmentationRecent DevelopmentsBiochip Regional LandscapeReport Scope:Biochip Competitive LandscapeGlobal biochip market is segmented as follows:RelatedNews
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed